-
公开(公告)号:US20240279331A1
公开(公告)日:2024-08-22
申请号:US18568218
申请日:2022-06-09
发明人: James A. Wells , Emily Kang , Lewis L. Lanier
CPC分类号: C07K16/2803 , C07K16/2887 , C07K16/32 , C07K2317/31 , C07K2317/55 , C07K2317/622 , C07K2317/732 , C07K2317/92
摘要: A functional screen to rapidly identify antibodies that can activate NK cells is provided as well as antibodies identified in the screen and their use.
-
公开(公告)号:US20200171135A1
公开(公告)日:2020-06-04
申请号:US16616435
申请日:2018-05-24
申请人: The Regents of the University of California , THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
IPC分类号: A61K39/00 , A61K39/395
摘要: The present invention provides vaccine compositions for preventing and/or treating cytomegalovirus (CMV) infection and methods of making and using the same.
-
3.
公开(公告)号:US09211328B2
公开(公告)日:2015-12-15
申请号:US13797921
申请日:2013-03-12
CPC分类号: A61K39/39541 , A61K2039/505 , C07K16/2851 , C07K2316/96 , C07K2317/73 , C07K2317/76 , Y10S514/885
摘要: The present invention relates to methods and compositions for treating and/or preventing autoimmune and/or inflammatory disease. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells, NK cells and/or NKT cells, by modulating NKG2D.
摘要翻译: 本发明涉及用于治疗和/或预防自身免疫和/或炎性疾病的方法和组合物。 特别地,本发明提供了通过调节NKG2D来损害自身反应性T细胞,NK细胞和/或NKT细胞的扩增和功能的治疗剂。
-
-